Drug-resistant Tuberculosis Treatment Market Size

Drug-resistant Tuberculosis Treatment Market size was over USD 1.27 Billion in 2023 and is projected to cross USD 1.90 Billion by the end of 2036, growing at more than 5.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of drug-resistant tuberculosis treatment is evaluated at USD 1.5 Billion.

The growing frequency of tuberculosis cases is driving up the drug-resistant tuberculosis market since it is the deadliest disease among all the other chronic diseases. According to WHO, 10 million people suffer from tuberculosis (TB) disease annually. This disease is preventable and curable but around 1.5 million people die every year from TB. The increasing pressure of tuberculosis in the population raises the requirement for precise diagnostic tests and treatment, which in turn is anticipated to propel the market growth.